Chinese Pharma Firm to Invest in Biomedical Industrial Park, an Industrial Info Market Brief

Zhejiang Medicine Company Limited is seeking an engineering, procurement and construction (EPC) firm for a proposed biomedical industrial park in Shaoxing, China.

Zhejiang Medicine Company plans to expand its role in China's biopharmaceutical, pharmaceutical-preparation and life-nutrition markets. The company hopes to begin site preparation in 2021.

Click here for a list of active pharmaceutical ingredient (API) projects in China, and see graph below for a breakdown by province.